R. Guidos

2.9k total citations · 2 hit papers
3 papers, 1.9k citations indexed

About

R. Guidos is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, R. Guidos has authored 3 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Medicine, 3 papers in Applied Microbiology and Biotechnology and 1 paper in Infectious Diseases. Recurrent topics in R. Guidos's work include Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (3 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). R. Guidos is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (3 papers) and Antibiotics Pharmacokinetics and Efficacy (1 paper). R. Guidos collaborates with scholars based in United States. R. Guidos's co-authors include Helen W. Boucher, David N. Gilbert, John S. Bradley, John G. Bartlett, John E. Edwards, W. Michael Scheld, Brad Spellberg, George H. Talbot, Barbara E. Murray and Robert A. Bonomo and has published in prestigious journals such as Clinical Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

R. Guidos

3 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

2007 1.3k citations Brad Spellberg, R. Guidos et al. Clinical Infectious Diseases profile →
10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

2013 555 citations Helen W. Boucher, George H. Talbot et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Guidos United States	3	746	483	469	407	368	3	1.9k
Elizabeth B. Hirsch United States	21	1.2k 1.6×	380 0.8×	364 0.8×	658 1.6×	578 1.6×	68	2.0k
Richard Bax United Kingdom	19	389 0.5×	261 0.5×	409 0.9×	424 1.0×	346 0.9×	31	1.8k
Alyssa Golden Canada	17	879 1.2×	265 0.5×	245 0.5×	564 1.4×	609 1.7×	44	1.6k
Jim O’Neill Ireland	6	568 0.8×	536 1.1×	441 0.9×	156 0.4×	228 0.6×	17	1.9k
Ayman Noreddin United States	25	1.1k 1.5×	315 0.7×	473 1.0×	1.0k 2.5×	984 2.7×	73	2.9k
Simona Pollini Italy	25	877 1.2×	176 0.4×	756 1.6×	225 0.6×	223 0.6×	45	2.0k
Danuta Stefanik Germany	23	1.4k 1.8×	231 0.5×	503 1.1×	489 1.2×	510 1.4×	29	2.1k
Stephen Rittenhouse United States	26	812 1.1×	166 0.3×	801 1.7×	607 1.5×	339 0.9×	43	2.2k
Erika Matuschek Sweden	20	613 0.8×	185 0.4×	320 0.7×	288 0.7×	396 1.1×	52	1.9k
Philip Lister United States	24	1.7k 2.3×	368 0.8×	985 2.1×	853 2.1×	591 1.6×	50	2.6k

Countries citing papers authored by R. Guidos

Since Specialization

Citations

This map shows the geographic impact of R. Guidos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Guidos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Guidos more than expected).

Fields of papers citing papers by R. Guidos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Guidos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Guidos. The network helps show where R. Guidos may publish in the future.

Co-authorship network of co-authors of R. Guidos

This figure shows the co-authorship network connecting the top 25 collaborators of R. Guidos. A scholar is included among the top collaborators of R. Guidos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Guidos. R. Guidos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Boucher, Helen W., George H. Talbot, Daniel K. Benjamin, et al.. (2013). 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America. Clinical Infectious Diseases. 56(12). 1685–1694. 555 indexed citations breakdown →

2.

Spellberg, Brad, R. Guidos, David N. Gilbert, et al.. (2007). The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clinical Infectious Diseases. 46(2). 155–164. 1258 indexed citations breakdown →

3.

Guidos, R., John G. Bartlett, Ethan Rubinstein, et al.. (2006). Anti-infective research and development—problems, challenges, and solutions. The Lancet Infectious Diseases. 7(1). 68–78. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact